- Free from Publisher MG Wulffelé, A Kooy, P Lehert, D Bets, JC … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Metformin improves glycemic control in poorly
controlled type 2 diabetic patients. Its effect in type 2 diabetic patients who
are intensively treated with insulin has not been studied. A total of 390 ... Cited by 68 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—HbA lc levels decreased in all groups, the lowest level occurring in
the insulin plus troglitazone group (insulin alone to 7.0%, insulin plus
metformin to 7.1%, and insulin plus troglitazone to 6.4%, P < 0.0001). The ... Cited by 61 - Related articles - BL Direct - All 6 versions
F Relimpio, A Pumar, F Losada, MA Mangas, … - Diabetic Medicine, 1998 - interscience.wiley.com To compare the effect of adding metformin to insulin therapy with a moderate
increase in insulin dose alone in insulin-treated, poorly controlled Type 2
diabetic patients, 47 consecutive such patients (baseline daily dose >0.5 ... Cited by 42 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] L Aviles-Santa, J Sinding, P Raskin - Annals of Internal Medicine, 1999 - Am Coll Physicians Larissa Avilés-Santa, MD; Joyce Sinding, MSN, RN; and Philip Raskin, MD ...
Background: Patients with type 2 diabetes are often obese and require large
doses of insulin to achieve glyce- mic control. Weight gain often ... Cited by 167 - Related articles - BL Direct - All 5 versions
HH Ponssen, JWF Elte, P Lehert, JP Schouten … - Clinical therapeutics, 2000 - Elsevier Thirty-one patients (24 women, 7 men; mean age, 61.8 years; mean body mass index
[BMI], 28.0 kg/m 2 ) were enrolled in this randomized, double-blind, 2-way,
crossover, placebo-controlled study. Patients with type 2 diabetes who were ... Cited by 27 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org SM Strowig, ML Avilés-Santa, P Raskin - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c levels decreased in both groups during dual therapy and
improved further during triple therapy (INS + MET 7.0 ± 0.8, INS + TGZ 6.2 ±
0.8, P < 0.0001; INS + MET, add TGZ 6.1 ± 0.4%, P < 0.001; INS + TGZ, add ... Cited by 49 - Related articles - BL Direct - All 5 versions
LS Hermann, J Kalen, P Katzman, I Lager, A … - Diabetes Obesity and Metabolism, 2001 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 10 - Related articles - BL Direct - All 4 versions
- Free from Publisher NJ Furlong, SA Hulme, SV O'Brien, KJ Hardy - Diabetes care, 2002 - Am Diabetes Assoc RESULTS—Baseline age, diabetes duration, insulin requirement, weight, BMI,
FBG, and HbA 1c (Diabetes Control and Complications Trial–aligned assay,
normal range 4.6–6.2%) were similar. Glycemic control improved ( ... Cited by 26 - Related articles - BL Direct - All 7 versions
L Landstedt-Hallin, U Adamson, P Arner, J … - Diabetes Care, 1995 - Am Diabetes Assoc OBJECTIVE--To compare the effect of bedtime NPH insulin or preprandial regular
insulin combined with glibenclamide on metabolic control in
non-insulin-dependent diabetes mellitus (NIDDM) patients with secondary ... Cited by 53 - Related articles - BL Direct - All 6 versions
AN Goudswaard, NJ Furlong, GE Rutten, RP … - Cochrane Database Syst Rev, 2004 - igitur-archive.library.uu.nl This is a reprint of a Cochrane review, prepared and maintained by The Cochrane
Collaboration and published in The Cochrane Library 2006, Issue 2 ... Insulin
monotherapy versus combinations of insulin with oral hypoglycaemic agents ... Cited by 42 - Related articles - View as HTML - All 8 versions
